We are live on ! Find out more
Third Rock Ventures

Third Rock Ventures Portfolio holdings

AUM $1.07B Turnover 20%
1-Year Est. Return 170.23%
This Fund
S&P 500
This Quarter Est. Return
-27.49%
1 Year Est. Return
+170.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$353M
AUM Growth
–
Cap. Flow
+$382M
Cap. Flow %
108.19%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
FMI
Foundation Medicine
FMI
+$184M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$127M
3
BLUE icon
bluebird bio
BLUE
+$71.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FMI
1
DELISTED
Foundation Medicine
FMI
$157M 44.57%
+6,569,645
New +$184M
2013 Q4
0 quarters
AGIO icon
2
Agios Pharmaceuticals
AGIO
$1.65B
$117M 33.07%
+5,564,414
New +$127M
2013 Q4
0 quarters
BLUE icon
3
DELISTED
bluebird bio
BLUE
$78.9M 22.36%
+255,839
New +$71.5M
2013 Q4
0 quarters

Similar funds

Third Rock Ventures's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Third Rock Ventures, which disclosed 3 positions worth $353M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Foundation Medicine: 6,569,645 shares worth $157M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Third Rock Ventures's largest Q4 2013 buy was Foundation Medicine: 6,569,645 shares worth $157M.
  • Third Rock Ventures's ten largest holdings make up 100% of its $353M portfolio in Q4 2013.
  • Third Rock Ventures disclosed 3 positions in Q4 2013, its first 13F filing on record.

Based on Third Rock Ventures's 13F filing for Q4 2013, filed 14 Feb 2014.